{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T16:32:33Z","timestamp":1758817953494,"version":"3.40.3"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2007,11,16]],"date-time":"2007-11-16T00:00:00Z","timestamp":1195171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2007,11,16]],"date-time":"2007-11-16T00:00:00Z","timestamp":1195171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biotechnol Lett"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1007\/s10529-007-9594-0","type":"journal-article","created":{"date-parts":[[2007,11,15]],"date-time":"2007-11-15T10:55:12Z","timestamp":1195124112000},"page":"571-579","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Exploiting cholera vaccines as a versatile antigen delivery platform"],"prefix":"10.1007","volume":"30","author":[{"given":"Anisia J.","family":"Silva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis O.","family":"Eko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge A.","family":"Benitez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,11,16]]},"reference":[{"key":"9594_CR1","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1128\/jcm.32.10.2345-2349.1994","volume":"32","author":"MJ Albert","year":"1994","unstructured":"Albert MJ (1994) Vibrio cholerae O139 Bengal. J Clin Microbiol 32:2345\u20132349","journal-title":"J Clin Microbiol"},{"key":"9594_CR2","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/0378-1119(94)90152-X","volume":"149","author":"MM B\u00e4ckstr\u00f6m","year":"1994","unstructured":"B\u00e4ckstr\u00f6m MM, Lebens F, Sch\u00f6del F, Holmgren J (1994) Insertion of a HIV-neutralizing epitope in a surface-exposed internal region of the cholera toxin B subunit. Gene 149:211\u2013217","journal-title":"Gene"},{"key":"9594_CR3","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1128\/iai.65.8.3474-3477.1997","volume":"65","author":"JA Benitez","year":"1997","unstructured":"Benitez JA, Spelbrink RG, Silva AJ et\u00a0al (1997) Adherence of Vibrio cholerae to cultured differentiated human intestinal cells: an in\u00a0vitro colonization model. Infect Immun 65:3474\u20133477","journal-title":"Infect Immun"},{"key":"9594_CR4","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1128\/IAI.67.2.539-545.1999","volume":"67","author":"JA Ben\u00edtez","year":"1999","unstructured":"Ben\u00edtez JA, Garc\u00eda L, Silva AJ et\u00a0al (1999) Preliminary assessment of the safety and immunogenicity of a new CTX\u03a6-negative, hemagglutinin\/protease-defective El Tor strain as a Cholera vaccine candidate. Infect Immun 67:539\u2013545","journal-title":"Infect Immun"},{"key":"9594_CR5","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/j.1365-2958.2006.05096.x","volume":"60","author":"SM Butler","year":"2006","unstructured":"Butler SM, Nelson EJ, Chowdhury N et\u00a0al (2006) Cholera stool bacteria repress chemotaxis to increase infectivity. Mol Microbiol 60:417\u2013426","journal-title":"Mol Microbiol"},{"key":"9594_CR6","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/0264-410X(93)90103-5","volume":"11","author":"JR Butterton","year":"1993","unstructured":"Butterton JR, Boyko SA, Calderwood SB (1993) Use of the Vibrio cholerae\n                           irgA gene as a locus for insertion and expression of heterologous antigens in cholera vaccine strains. Vaccine 11:1327\u20131335","journal-title":"Vaccine"},{"key":"9594_CR7","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1128\/iai.63.7.2689-2696.1995","volume":"63","author":"JR Butterton","year":"1995","unstructured":"Butterton JR, Beattie DT, Gardel CL et\u00a0al (1995) Heterologous antigen expression in Vibrio cholerae vector strains. Infect Immun 63:2689\u20132696","journal-title":"Infect Immun"},{"key":"9594_CR8","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1128\/iai.65.6.2127-2135.1997","volume":"65","author":"JR Butterton","year":"1997","unstructured":"Butterton JR, Ryan ET, Acheson DW et\u00a0al (1997) Coexpression of the B subunit of Shiga toxin 1 and EaeA from enterohemorrhagic Escherichia coli in Vibrio cholerae vaccine strains. Infect Immun 65:2127\u20132135","journal-title":"Infect Immun"},{"key":"9594_CR9","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1111\/j.1365-2958.1995.mmi_18040671.x","volume":"18","author":"A Camilli","year":"1995","unstructured":"Camilli A, Mekalanos JJ (1995) Use of recombinase gene fusions to identify Vibrio cholerae genes induced during infection. Mol Microbiol 18:671\u2013683","journal-title":"Mol Microbiol"},{"key":"9594_CR10","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1128\/IAI.66.4.1648-1653.1998","volume":"66","author":"I Chen","year":"1998","unstructured":"Chen I, Finn TM, Yanqing L et\u00a0al (1998) A recombinant live attenuated strain of Vibrio cholerae induces immunity against tetanus toxin and Bordetella pertussis tracheal colonization factor. Infect Immun 66:1648\u20131653","journal-title":"Infect Immun"},{"key":"9594_CR11","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1046\/j.1365-2958.1998.00726.x","volume":"27","author":"SL Chiang","year":"1998","unstructured":"Chiang SL, Mekalanos JJ (1998) Use of signature-tagged transposon mutagenesis to identify Vibrio cholerae genes critical for colonization. Mol Microbiol 27:797\u2013805","journal-title":"Mol Microbiol"},{"key":"9594_CR12","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1128\/IAI.70.4.1965-1970.2002","volume":"70","author":"MB Cohen","year":"2002","unstructured":"Cohen MB, Giannella RA, Bean J et\u00a0al (2002) Randomized, controlled human challenge study of the safety, immunogenicity, and protective efficacy of a single dose of Peru-15, a live attenuated oral cholera vaccine. Infect Immun 70:1965\u20131970","journal-title":"Infect Immun"},{"key":"9594_CR13","first-page":"35","volume":"146","author":"R Curtis III","year":"1989","unstructured":"Curtis III R, Kelly SM, Gulig PA et\u00a0al (1989) Selective delivery of antigens by recombinant bacteria. Curr Top Microbiol Immunol 146:35\u201339","journal-title":"Curr Top Microbiol Immunol"},{"key":"9594_CR14","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/S0264-410X(98)00423-X","volume":"17","author":"FO Eko","year":"1999","unstructured":"Eko FO, Witte A, Huter V et\u00a0al (1999) New strategies for combination vaccines based on the extended recombinant bacterial ghost system. Vaccine 17:1643\u20131649","journal-title":"Vaccine"},{"key":"9594_CR15","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0168-1656(00)00315-1","volume":"83","author":"FO Eko","year":"2000","unstructured":"Eko FO, Mayr UB, Attridge SR et\u00a0al (2000) Characterization and immunogenicity of Vibrio cholerae ghosts expressing toxin-coregulated pili. J Biotechnol 83:115\u2013123","journal-title":"J Biotechnol"},{"key":"9594_CR16","doi-asserted-by":"publisher","first-page":"3663","DOI":"10.1016\/S0264-410X(03)00388-8","volume":"21","author":"FO Eko","year":"2003","unstructured":"Eko FO, Schukovskaya T, Lotzmanova EY et\u00a0al (2003) Evaluation of the protective efficacy of Vibrio cholerae ghost (VCG) candidate vaccines in rabbits. Vaccine 21:3663\u20133674","journal-title":"Vaccine"},{"key":"9594_CR17","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.4049\/jimmunol.173.5.3375","volume":"173","author":"FO Eko","year":"2004","unstructured":"Eko FO, He Q, Brown T et\u00a0al (2004) A novel recombinant multisubunit vaccine against Chlamydia. J Immunol 173:3375\u20133382","journal-title":"J Immunol"},{"key":"9594_CR18","doi-asserted-by":"publisher","first-page":"5242","DOI":"10.1073\/pnas.88.12.5242","volume":"88","author":"A Fasano","year":"1991","unstructured":"Fasano A, Baudry B, Pumplin DW et\u00a0al (1991) Vibrio cholerae produces a second enterotoxin, which affects intestinal tight junctions. Proc Natl Acad Sci USA 88:5242\u20135246","journal-title":"Proc Natl Acad Sci USA"},{"key":"9594_CR19","doi-asserted-by":"publisher","first-page":"4354","DOI":"10.1016\/j.vaccine.2006.02.052","volume":"24","author":"D Favre","year":"2006","unstructured":"Favre D, L\u00fcdi S, Stoffel M et\u00a0al (2006) Expression of enterotoxigenic Escherichia coli colonization factors in Vibrio cholerae. Vaccine 24:4354\u20134368","journal-title":"Vaccine"},{"key":"9594_CR20","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/978-1-4757-9688-9_8","volume-title":"Cholera","author":"RA Finkelstein","year":"1992","unstructured":"Finkelstein RA (1992) Cholera enterotoxin (choleragen): a historical perspective. In: Barua D, Greenough WB (eds) Cholera. Plenum Medical Book Company, New York, pp 155\u2013187"},{"key":"9594_CR21","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0264-410X(00)00137-7","volume":"19","author":"MR Fontana","year":"2001","unstructured":"Fontana MR, Monaci E, Yanqing L et\u00a0al (2001) IEM101, a naturally attenuated Vibrio cholerae strain as carrier for genetically detoxified derivatives of cholera toxin. Vaccine 19:75\u201385","journal-title":"Vaccine"},{"key":"9594_CR22","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.1128\/IAI.73.5.3018-3024.2005","volume":"73","author":"L Garc\u00eda","year":"2005","unstructured":"Garc\u00eda L, Jidy MD, Garcia H et\u00a0al (2005) The vaccine candidate Vibrio\n                           cholerae 638 is protective against cholera in healthy volunteers. Infect Immun 73:3018\u20133024","journal-title":"Infect Immun"},{"key":"9594_CR23","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0378-1119(96)00424-6","volume":"179","author":"I Gentschev","year":"1996","unstructured":"Gentschev I, Mollenkopf H, Sokolovic Z et\u00a0al (1996) Development of antigen-delivery systems, based on the Escherichia coli hemolysin secretion pathway. Gene 179:133\u2013140","journal-title":"Gene"},{"key":"9594_CR24","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1016\/S0264-410X(00)00502-8","volume":"19","author":"I Gentschev","year":"2001","unstructured":"Gentschev I, Dietrich G, Spreng S et\u00a0al (2001) Recombinant attenuated bacteria for the delivery of subunit vaccines. Vaccine 19:2621\u20132628","journal-title":"Vaccine"},{"key":"9594_CR25","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0966-842X(01)02259-4","volume":"10","author":"I Gentschev","year":"2002","unstructured":"Gentschev I, Dietrich G, Goebel W (2002) The E.\u00a0coli \u03b1-hemolysin secretion system and its use in vaccine development. Trends Microbiol 10:39\u201344","journal-title":"Trends Microbiol"},{"key":"9594_CR26","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/0014-5793(96)00475-9","volume":"387","author":"A Ghorpade","year":"1996","unstructured":"Ghorpade A, Garg LC (1996) Efficient expression, processing and secretion of a biologically active mammalian protein in Vibrio cholerae. FEBS Lett 387:167\u2013170","journal-title":"FEBS Lett"},{"key":"9594_CR27","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1128\/jb.173.11.3311-3317.1991","volume":"173","author":"CC H\u00e4se","year":"1991","unstructured":"H\u00e4se CC, Finkelstein RA (1991) Cloning and nucleotide sequence of the Vibrio cholerae hemagglutinin\/protease (HA\/protease) gene and construction of an HA\/protease-negative strain. J Bacteriol 173:3311\u20133317","journal-title":"J Bacteriol"},{"key":"9594_CR28","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s10529-007-9359-9","volume":"29","author":"A Hazra","year":"2007","unstructured":"Hazra A, Silva AJ, Benitez JA (2007) Expression of foreign proteins in a Vibrio cholerae vaccine strain using the stationary phase hemagglutinin\/protease promoter. Biotechnol Lett 29:1093\u20131097","journal-title":"Biotechnol Lett"},{"key":"9594_CR29","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1084\/jem.168.4.1487","volume":"168","author":"DA Herrington","year":"1988","unstructured":"Herrington DA, Hall RH, Losonsky GA et\u00a0al (1988) Toxin, the toxin co-regulated pili and the toxR regulon are essential for Vibrio cholerae pathogenesis in humans. J Exp Med 168:1487\u20131492","journal-title":"J Exp Med"},{"key":"9594_CR30","first-page":"188","volume":"40","author":"G Ifere","year":"2007","unstructured":"Ifere G, He Q, Igietseme JU et\u00a0al (2007) Immunogenicity and protection against genital Chlamydia infection and its complications by a multisubunit candidate vaccine. J Microbiol Immunol Infect 40:188\u2013200","journal-title":"J Microbiol Immunol Infect"},{"key":"9594_CR31","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1128\/IAI.68.2.986-989.2000","volume":"68","author":"V Jain","year":"2000","unstructured":"Jain V, Mekalanos JJ (2000) Use of lambda phage S and R gene products in an inducible lysis system for Vibrio cholerae- and Salmonella enterica serovar typhimurium-based DNA vaccine delivery systems. Infect Immun 68:986\u2013989","journal-title":"Infect Immun"},{"key":"9594_CR32","doi-asserted-by":"crossref","first-page":"4915","DOI":"10.1128\/iai.60.11.4915-4924.1992","volume":"60","author":"MG Jobling","year":"1992","unstructured":"Jobling MG, Holmes RK (1992) Fusion proteins containing the A2 domain of cholera toxin assemble with B polypeptides of cholera toxin to form immunoreactive and functional holotoxin-like chimeras. Infect Immun 60:4915\u20134924","journal-title":"Infect Immun"},{"key":"9594_CR33","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1128\/IAI.68.3.1171-1175.2000","volume":"68","author":"M John","year":"2000","unstructured":"John M, Crean TI, Calderwood SB et\u00a0al (2000) In\u00a0vitro and in\u00a0vivo analyses of constitutive and in\u00a0vivo-induced promoters in attenuated vaccine and vector strains of Vibrio cholerae. Infect Immun 68:1171\u20131175","journal-title":"Infect Immun"},{"key":"9594_CR34","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1128\/CMR.8.1.48","volume":"8","author":"JB Kaper","year":"1995","unstructured":"Kaper JB, Morris Jr G, Levine MM (1995) Cholera. Clin Microbiol Rev 8:48\u201386","journal-title":"Clin Microbiol Rev"},{"key":"9594_CR35","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/infdis\/172.4.1126","volume":"172","author":"JR Kenner","year":"1995","unstructured":"Kenner JR, Coster TS, Taylor DN et\u00a0al (1995) Peru-15, an improved live attenuated oral vaccine candidate for Vibrio cholerae O1. J Infect Dis 172:1126\u20131129","journal-title":"J Infect Dis"},{"key":"9594_CR36","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/S0092-8674(00)81551-2","volume":"99","author":"SH Lee","year":"1999","unstructured":"Lee SH, Hava DL, Waldor MK et\u00a0al (1999) Regulation and temporal expression patterns of Vibrio cholerae virulence genes during infection. Cell 99:625\u2013634","journal-title":"Cell"},{"key":"9594_CR37","doi-asserted-by":"publisher","first-page":"6889","DOI":"10.1073\/pnas.111581598","volume":"98","author":"SH Lee","year":"2001","unstructured":"Lee SH, Butler SM, Camilli A (2001) Selection for in\u00a0vivo regulators of bacterial virulence. Proc Natl Acad Sci USA 98:6889\u20136894","journal-title":"Proc Natl Acad Sci USA"},{"key":"9594_CR38","first-page":"395","volume-title":"Vibrio cholerae and cholera: molecular to global perspective","author":"MM Levine","year":"1994","unstructured":"Levine MM, Tacket CO (1994) Recombinant live cholera vaccines. In: Wachsmuth IK, Blake PA, Olsvik O (eds) Vibrio cholerae and cholera: molecular to global perspective. Amer. Soc. Microbiol., Washington, pp 395\u2013413"},{"key":"9594_CR39","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1128\/iai.43.2.515-522.1984","volume":"43","author":"MM Levine","year":"1984","unstructured":"Levine MM, Black RE, Clements ML et\u00a0al (1984) Evaluation in humans of the attenuated Vibrio cholerae El Tor Ogawa strain Texas Star-SR as a live oral vaccine. Infect Immun 43:512\u2013522","journal-title":"Infect Immun"},{"key":"9594_CR40","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1073\/pnas.96.3.1071","volume":"96","author":"W Lin","year":"1999","unstructured":"Lin W, Fullner KJ, Clayton R et\u00a0al (1999) Identification of a Vibrio cholerae RTX toxin gene cluster that is tightly linked to the cholera toxin prophage. Proc Natl Acad Sci USA 96:1071\u20131076","journal-title":"Proc Natl Acad Sci USA"},{"key":"9594_CR41","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/j.1574-695X.2006.00165.x","volume":"49","author":"L Macmillan","year":"2007","unstructured":"Macmillan L, Ifere GO, He Q et\u00a0al (2007) A recombinant multivalent combination vaccine protects against Chlamydia and genital herpes. FEMS Immunol Med Microbiol 49:46\u201355","journal-title":"FEMS Immunol Med Microbiol"},{"key":"9594_CR42","doi-asserted-by":"crossref","first-page":"4462","DOI":"10.1128\/iai.61.10.4462-4468.1993","volume":"61","author":"J Michalski","year":"1993","unstructured":"Michalski J, Galen JE, Fasano A et\u00a0al (1993) CVD110, an attenuated Vibrio cholerae O1 El Tor live oral vaccine strain. Infect Immun 61:4462\u20134468","journal-title":"Infect Immun"},{"key":"9594_CR43","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1128\/IAI.73.2.972-980.2005","volume":"73","author":"CG Osorio","year":"2005","unstructured":"Osorio CG, Crawford JA, Michalski JA et\u00a0al (2005) Second-generation recombination-based in\u00a0vivo expression technology for large-scale screening for Vibrio cholerae genes induced during infection of the mouse small intestine. Infect Immun 73:972\u2013980","journal-title":"Infect Immun"},{"key":"9594_CR44","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/0140-6736(91)92590-X","volume":"338","author":"H Peltola","year":"1991","unstructured":"Peltola H, Siitonen A, Kyronseppa H et\u00a0al (1991) Prevention of traveler\u2019s diarrhea by oral B-subunit\/whole-cell cholera vaccine. Lancet 338:1285\u20131289","journal-title":"Lancet"},{"key":"9594_CR45","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/0168-1656(95)00140-9","volume":"44","author":"PH Pouwels","year":"1996","unstructured":"Pouwels PH, Leer RJ, Boersma WJ (1996) The potential of Lactobacillus as a carrier for oral immunization: development and preliminary characterization of a vector system for targeted delivery of antigens. J Biotechnol 44:183\u2013192","journal-title":"J Biotechnol"},{"key":"9594_CR46","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0168-1605(98)00048-8","volume":"41","author":"PH Pouwels","year":"1998","unstructured":"Pouwels PH, Leer RJ, Shaw M et\u00a0al (1998) Lactic acid bacteria as antigen delivery vectors for oral immunization purposes Int. J Food Microbiol 41:155\u2013167","journal-title":"J Food Microbiol"},{"key":"9594_CR47","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1086\/432074","volume":"192","author":"F Qadri","year":"2005","unstructured":"Qadri F, Chowdhury MI, Faruque SM et\u00a0al (2005) Randomized, controlled study of the safety and immunogenicity of Per\u00fa-15, a live attenuated oral vaccine candidate for cholera, in adult volunteers in Bangladesh . J Infect Dis 192:573\u2013579","journal-title":"J Infect Dis"},{"key":"9594_CR48","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.vaccine.2006.08.031","volume":"25","author":"F Qadri","year":"2007","unstructured":"Qadri F, Chowdhury MI, Faruque SM et\u00a0al (2007) Peru-15, a live attenuated oral cholera vaccine, is safe and immunogenic in Bangladeshi toddlers and infants. Vaccine 25:231\u2013238","journal-title":"Vaccine"},{"key":"9594_CR49","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1016\/S0264-410X(00)00006-2","volume":"18","author":"EE Richie","year":"2000","unstructured":"Richie EE, Punjabi NH, Sidharta YY et\u00a0al (2000). Efficacy of single dose live oral vaccine CVD 103-HgR in north Jakarta, Indonesia, a cholera-endemic area. Vaccine 18:2399\u20132410","journal-title":"Vaccine"},{"key":"9594_CR50","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1016\/S0264-410X(96)00105-3","volume":"14","author":"A Robert","year":"1996","unstructured":"Robert A, Silva AJ, Ben\u00edtez JA et\u00a0al (1996) Tagging a Vibrio cholerae El Tor candidate vaccine strain by disruption of its hemagglutinin\/protease gene using a novel reporter gene: Clostridium thermocellum endoglucanase A. Vaccine 14:1517\u20131522","journal-title":"Vaccine"},{"key":"9594_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1462-5822.2004.00477.x","volume":"7","author":"SM Rollins","year":"2005","unstructured":"Rollins SM, Peppercorn A, Hang L et\u00a0al (2005) In\u00a0vivo induced antigen technology (IVIAT). Cell Microbiol 7:1\u20139","journal-title":"Cell Microbiol"},{"key":"9594_CR52","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1128\/iai.65.7.2941-2949.1997","volume":"65","author":"ET Ryan","year":"1997","unstructured":"Ryan ET, Butterton JR, Smith RN et\u00a0al (1997a) Protective immunity against Clostridium difficile toxin A induced by oral immunization with a live, attenuated Vibrio cholerae vector strain. Infect Immun 65:2941\u20132949","journal-title":"Infect Immun"},{"key":"9594_CR53","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1128\/iai.65.8.3118-3125.1997","volume":"65","author":"ET Ryan","year":"1997","unstructured":"Ryan ET, Butterton JR, Zhang T et\u00a0al (1997b) Oral immunization with attenuated vaccine strains of Vibrio cholerae expressing a dodecapeptide repeat of the serine-rich Entamoeba histolytica protein fused to the Cholera toxin B subunit induces systemic and mucosal antiamebic and anti-V. cholerae antibody responses in mice. Infect Immun 65:3118\u20133125","journal-title":"Infect Immun"},{"key":"9594_CR54","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1128\/IAI.67.4.1694-1701.1999","volume":"67","author":"ET Ryan","year":"1999","unstructured":"Ryan ET, Crean TI, John M et\u00a0al (1999) In\u00a0vivo expression and immunoadjuvancy of a mutant of heat-labile enterotoxin of Escherichia coli in vaccine and vector strains of Vibrio cholerae. Infect Immun 67:1694\u20131701","journal-title":"Infect Immun"},{"key":"9594_CR55","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1128\/IAI.68.12.7100-7113.2000","volume":"68","author":"ET Ryan","year":"2000","unstructured":"Ryan ET, Crean TI, Kochi SK et\u00a0al (2000) Development of a \u0394glnA balanced lethal plasmid system for expression of heterologous antigens by attenuated vaccine vector strains of Vibrio cholerae. Infect Immun 68:221\u2013226","journal-title":"Infect Immun"},{"key":"9594_CR56","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/0014-5793(88)81041-X","volume":"241","author":"J Sanchez","year":"1988","unstructured":"Sanchez J, Svennerholm AM, Holmgren J (1988). Genetic fusion of a non-toxic heat-stable enterotoxin-related decapeptide antigen to cholera toxin B-subunit. FEBS Lett 241:110\u2013114","journal-title":"FEBS Lett"},{"key":"9594_CR57","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0923-2508(90)90137-F","volume":"141","author":"J Sanchez","year":"1990","unstructured":"Sanchez J, Johansson S, L\u00f6wenadler B et\u00a0al (1990) Recombinant cholera toxin B subunit and gene fusion proteins for oral vaccination. Res Microbiol 141:971\u2013979","journal-title":"Res Microbiol"},{"key":"9594_CR58","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/0378-1119(91)90135-X","volume":"99","author":"F Sch\u00f6del","year":"1991","unstructured":"Sch\u00f6del F, Will H, Johansson S et\u00a0al (1991) Synthesis in Vibrio cholerae and secretion of hepatitis B virus antigens fused to Escherichia coli heat-labile enterotoxin B subunit. Gene 99:255\u2013259","journal-title":"Gene"},{"key":"9594_CR59","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S1357-4310(99)01633-0","volume":"6","author":"MT Shata","year":"2000","unstructured":"Shata MT, Srtevceva L, Agwale S et\u00a0al (2000) Recent advances with recombinant bacterial vectors. Mol Med Today 6:66\u201371","journal-title":"Mol Med Today"},{"key":"9594_CR60","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.femsim.2004.10.001","volume":"43","author":"AJ Silva","year":"2005","unstructured":"Silva AJ, Benitez JA (2005) Th1-type immune response to a Coccidioides immitis antigen delivered by an attenuated strain of the non-invasive enteropathogen Vibrio cholerae. FEMS Immunol Med Microbiol 43:393\u2013398","journal-title":"FEMS Immunol Med Microbiol"},{"key":"9594_CR61","doi-asserted-by":"publisher","first-page":"4715","DOI":"10.1016\/S0264-410X(03)00515-2","volume":"21","author":"AJ Silva","year":"2003","unstructured":"Silva AJ, Mohan A, Benitez JA (2003) Cholera vaccine candidate 638: Intranasal immunogenicity and expression of a foreign antigen from the pulmonary pathogen Coccidioides\n                           immitis. Vaccine 21:4715\u20134721","journal-title":"Vaccine"},{"key":"9594_CR62","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1128\/IAI.74.4.2072-2079.2006","volume":"74","author":"AJ Silva","year":"2006","unstructured":"Silva AJ, Leitch GJ, Camilli A et\u00a0al (2006) Contribution of hemagglutinin\/protease and motility to the pathogenesis of El Tor biotype cholera. Infect Immun 74:2072\u20132079","journal-title":"Infect Immun"},{"key":"9594_CR63","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/S0264-410X(96)00252-6","volume":"15","author":"DR Sizemore","year":"1997","unstructured":"Sizemore DR, Branstrom AA, Sadoff JC (1997) Attenuated bacteria as a DNA delivery vehicle for DNA-mediated immunization. Vaccine 15:804\u2013807","journal-title":"Vaccine"},{"key":"9594_CR64","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/j.1574-695X.2000.tb01443.x","volume":"27","author":"S Spreng","year":"2000","unstructured":"Spreng S, Dietrich S, Niewiesk S et\u00a0al (2000) Novel bacterial system for delivery of recombinant protein or DNA. FEMS Immunol Med Microbiol 27:299\u2013304","journal-title":"FEMS Immunol Med Microbiol"},{"key":"9594_CR65","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1128\/IAI.66.2.462-468.1998","volume":"66","author":"F Sultan","year":"1998","unstructured":"Sultan F, Jin LI, Jobling MG et\u00a0al (1998) Mucosal immunogenicity of a holotoxin-like molecule containing the serine-rich Entamoeba histolytica protein (SREHP) fused to the A2 domain of cholera toxin. Infect Immun 66:462\u2013468","journal-title":"Infect Immun"},{"key":"9594_CR66","unstructured":"Szostak MP, Lubitz W (1991) Recombinant bacterial ghosts as multivaccine vehicles. Vaccine 91: modern approaches to new vaccines including prevention of AIDS. Cold Spring Harbor Laboratory Press, Cold Spring Harbor"},{"key":"9594_CR67","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1093\/infdis\/168.6.1536","volume":"168","author":"CO Tacket","year":"1993","unstructured":"Tacket CO, Losonsky G, Nataro JP et\u00a0al (1993) Safety and immunogenicity of live oral cholera vaccine candidate CVD110, a \u0394ctxA\u0394zot\u0394ace derivative of El Tor Ogawa Vibrio cholerae. J Infect Dis 168:1536\u20131540","journal-title":"J Infect Dis"},{"key":"9594_CR68","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S0140-6736(96)06107-7","volume":"349","author":"DD Trach","year":"1997","unstructured":"Trach DD, Clemens JD, Ke NT et\u00a0al (1997) Field trial of a locally produced, killed, oral cholera vaccine in Vietnam. Lancet 349:231\u2013235","journal-title":"Lancet"},{"key":"9594_CR69","doi-asserted-by":"publisher","first-page":"5267","DOI":"10.1073\/pnas.90.11.5267","volume":"90","author":"M Trucksis","year":"1993","unstructured":"Trucksis M, Galen JE, Michalski J et\u00a0al (1993) Accessory cholera enterotoxin (Ace), the third toxin of a Vibrio cholerae virulence cassette. Proc Natl Acad Sci USA 90:5267\u20135271","journal-title":"Proc Natl Acad Sci USA"},{"key":"9594_CR70","doi-asserted-by":"publisher","first-page":"6411","DOI":"10.1128\/IAI.68.11.6411-6418.2000","volume":"68","author":"E Valle","year":"2000","unstructured":"Valle E, Ledon T, Cedre B et\u00a0al (2000) Construction and characterization of a non-proliferative El Tor cholera vaccine candidate derived from strain 638. Infect Immun 68:6411\u20136418","journal-title":"Infect Immun"},{"key":"9594_CR71","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/0264-410X(95)00122-H","volume":"14","author":"FP Van Loon","year":"1996","unstructured":"Van Loon FP, Clemens JD, Chakraborty J et\u00a0al (1996) Field trial of inactivated oral cholera vaccines in Bangladesh: results from a 5\u00a0years follow-up. Vaccine 14:162\u2013166","journal-title":"Vaccine"},{"key":"9594_CR72","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1126\/science.272.5270.1910","volume":"272","author":"MK Waldor","year":"1996","unstructured":"Waldor MK, Mekalanos JJ (1996) Lysogenic conversion by a filamentous phage encoding cholera toxin. Science 272:1910\u20131914","journal-title":"Science"},{"key":"9594_CR73","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0300-9084(90)90145-7","volume":"72","author":"A Witte","year":"1990","unstructured":"Witte A, Blasi U et\u00a0al (1990) Phi X174 protein E-mediated lysis of Escherichia coli. Biochemie 72:191\u2013200","journal-title":"Biochemie"},{"key":"9594_CR74","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1073\/pnas.0337479100","volume":"100","author":"Q Xu","year":"2003","unstructured":"Xu Q, Dziejman M, Mekalanos JJ (2003) Determination of the transcriptome of Vibrio cholerae during intraintestinal growth and midexponential phase in\u00a0vitro. Proc Natl Acad Sci USA 100:1286\u20131291","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Biotechnology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10529-007-9594-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10529-007-9594-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10529-007-9594-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10529-007-9594-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T02:19:53Z","timestamp":1744165193000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10529-007-9594-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11,16]]},"references-count":74,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["9594"],"URL":"https:\/\/doi.org\/10.1007\/s10529-007-9594-0","relation":{},"ISSN":["0141-5492","1573-6776"],"issn-type":[{"type":"print","value":"0141-5492"},{"type":"electronic","value":"1573-6776"}],"subject":[],"published":{"date-parts":[[2007,11,16]]},"assertion":[{"value":"27 September 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2007","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2007","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}